Lipid Apheresis project with the Royal Brompton & Harefield Hospitals
investigate the effects of therapeutic apheresis with either filtration or immunoadsorption on fatigue in patients with Post COVID Syndrome
assess the safety and tolerability of the treatment
compare the efficacy of the different apheresis methods in relieving fatigue and other symptoms
investigate the effects of apheresis on autoantibodies, inflammation markers and blood viscosity parameters in patients with Post COVID syndrome
examine whether any of those parameters correlate with specific symptoms and their severity
APHRODITE: APHeResis for post-cOviD – an Investigational Treatment of Extended Fatigue after SARS-CoV-2 Infection
Objectives:
Largest Lipid apheresis Centre in the UK, now official partner of King’s College London in collaboration with Imperial College
Currently setting up the logistics of a Lipid Apheresis Unit for Lipid patients as well as Long-Covid patients at Cromwell Hospital in Kensington
A lipid apheresis unit business plan has been approved at St-Thomas’s hospital, currently in process of identifying a suitable location to set up the new unit; Harefield is one of 8 centres in UK
